Shane Hilary Buys 215,336 Shares After FONAR Corp. Delists, Betting on Post‑Merger Growth

Insider Buying Surge at FONAR Corp

The latest filing from June 2 2026 shows a significant purchase of 196,336 shares by Shane Hilary through ODS Capital LLC, followed shortly by a second transaction of 19,000 shares via the Oliver Shane Irrevocable Trust. At a price of $19.10 per share, these buys bring Hilary’s post‑transaction holdings to roughly 520,609 shares, a noticeable increase from the 324,273 shares recorded just a week earlier. The timing of these purchases—immediately after the company’s delisting and merger with its parent—suggests a confidence in the newly structured entity, despite the cessation of public trading on Nasdaq.

Implications for Investors and the Company’s Future

For investors who still hold shares or are considering a position, the insider activity signals a bullish stance from the owner. Historically, Hilary has been a consistent buyer, adding between 71,000 and 225,000 shares in late May. Such repeated purchases in a short period can be interpreted as a belief that the company’s intrinsic value is currently undervalued by the market, or as an attempt to consolidate control following the merger. However, the delisting removes the liquidity and regulatory transparency that public shareholders rely on, meaning future trading will likely be limited to private transactions or secondary markets. Investors should weigh the potential upside of an eventual secondary offering against the lack of price discovery and limited disclosure.

Shane Hilary: A Profile of the Insider

Shane Hilary’s trading pattern is characterized by sizable, frequent purchases rather than sporadic sales or short‑term speculation. Over the past month, he has added more than 500,000 shares in total, with a clear preference for buying at or near the market price rather than attempting to time the stock. This consistent buying behavior aligns with a long‑term investment thesis and a belief that the company’s fundamentals—particularly its MRI scanner technology and physician‑practice management services—will drive growth. The recent merger may have provided a catalyst for Hilary to secure a larger stake, positioning himself as a key shareholder in the newly formed corporate structure.

What This Means for the Health‑Care Equipment Sector

FONAR’s transition from a publicly traded entity to a wholly‑owned subsidiary marks a significant shift for the health‑care equipment industry. The company’s magnetic resonance imaging (MRI) scanners remain a critical diagnostic tool, and the consolidation with its parent could streamline operations and reduce overhead. Hilary’s continued investment indicates that insider confidence may translate into strategic investments in research and development, potentially enhancing the company’s competitive edge. For investors in the broader sector, watching how FONAR navigates post‑merger integration and whether it eventually re‑enters the public markets will be crucial for assessing long‑term value creation.

Looking Ahead

With the current transaction occurring after the company’s delisting, the next steps for FONAR will likely involve private equity financing, strategic partnerships, or a future IPO. Insider buying is a positive signal, but investors must remain vigilant about the risks associated with private ownership, such as limited liquidity and reduced disclosure. As the company continues to evolve, monitoring both insider activity and the broader health‑care equipment market will provide insights into its potential for sustainable growth and shareholder returns.